Heart-Rate Variability Is Not a Fear Meter: Designing an NSI Measurement Protocol

Define the signal before naming a psychological state

Heart-rate variability describes variation in the time intervals between heartbeats. It is valuable in cardiovascular and psychophysiological research, but a single HRV value cannot uniquely identify fear, cognitive control or trading readiness. Laborde, Mosley and Thayer set out methodological recommendations covering experiment planning, analysis and reporting, emphasizing the dependence of interpretation on measurement conditions [1]. A valid research protocol specifies whether the recording uses electrocardiography or an optical wearable, how interbeat intervals are cleaned, what recording window is analyzed and which frequency or time-domain metrics are reported. Without those details, an attractive dashboard score gives an illusion of biological precision without a reproducible definition.

Even if a metric correlates with a condition in a sample, it does not follow that an individual's low reading is a diagnosis or that the reading predicts a specific decision. Cardiac rhythms vary with respiration, posture, movement, medication, illness and measurement artifacts. Some of these factors also vary systematically across a trading day. If a participant stands up after a difficult trade, both stress and posture might change simultaneously, and the observed HRV difference would not isolate either cause. A research-grade system must document such potential confounders rather than hide them behind an all-purpose 'stress' label.

Respiration and the problem of measurement equivalence

Kromenacker and colleagues studied the vagal mediation of low-frequency HRV during slow breathing [2]. Their work helps explain why an HRV shift during paced breathing cannot be interpreted in the same way as a shift under uncontrolled natural respiration. Respiratory frequency moves signal power across conventional bands and changes the relationship between the numerical index and the mechanism of interest. A device may correctly report an increase in an HRV statistic while the researcher remains unable to say whether emotion, breathing pattern or another variable primarily accounts for it. The measurement may be real, but the inference may be unsupported.

A further methodological problem is between-person comparison. A resting recording from one individual is not directly interchangeable with another individual's value because baseline physiology and recording context differ. Simple rank-order labels such as 'weak nervous system' and 'strong nervous system' can stigmatize participants while adding no testable explanatory value. If NSI proposes to use HRV, it should first establish within-person reliability, device agreement, minimal detectable change and the extent to which respiration and physical activity explain the series. Only then should investigators ask whether the measure adds information about decisions.

What trading physiology studies can and cannot contribute

Coates and Herbert reported associations among endogenous steroids, market conditions and trading outcomes in a naturalistic study on a London trading floor [3]. Although their primary measurements were hormonal rather than HRV, the research demonstrates the importance and the limitations of studying physiology during real financial activity. The findings should not be treated as validation of a new composite nervous-system score. The underlying population, measurement frequency, observational design and alternative explanations matter. NSI requires independent tests of its own constructs and endpoints; proximity to a respected scientific literature does not substitute for validation.

Reliability deserves separate study from predictive relevance. A measure can be highly repeatable yet unrelated to the behavioral construct being investigated, or related on average while too noisy for individual use. Researchers should therefore estimate test-retest characteristics, agreement among devices and sensitivity to movement artifacts before evaluating decision outcomes. They should also prespecify handling for ectopic beats and missing intervals, because filtering choices can materially alter summary measures. In multi-day field recordings, the time of measurement must be consistent or explicitly modeled. It is especially misleading to compare a two-minute reading obtained during hurried breathing with a longer quiet resting baseline. The responsible reporting standard is to make these details visible and to avoid converting statistical group differences into categorical personal judgments.

A realistic study would timestamp financial events and consented physiological recordings, prespecify relevant decision outcomes and log respiration, movement, sleep and position exposure. It would first compare a behavioral-only baseline model with a model adding HRV metrics. A positive association should then be tested on participants and sessions not used to develop the model. Researchers must report performance uncertainty, missing data and subgroup differences, and must evaluate privacy before collecting sensitive measurements. A useful related article, The Five Dimensions of the Nervous System Indicator, outlines the conceptual domains; Can Your Nervous System Predict Gold Prices? explains why physiological evidence does not confer a gold-price forecasting capability.

In conclusion, HRV is a physiological observation whose meaning depends on context, not a universal emotional label. A rigorous NSI protocol would state what the signal measures, what it cannot measure and exactly how it enters an independently tested behavioral hypothesis. The intellectually defensible ambition is to learn whether HRV adds reproducible information about decision consistency beyond simpler data. Until that is shown, NSI should remain a proposed research framework, not a clinical instrument or performance-prediction product.